Skip to main content
Clinical Trials/CTRI/2024/04/066496
CTRI/2024/04/066496CompletedUnknown

MissoBOT-A prospective, single-arm, multi-center, post-marketing surveillance study to evaluate the safety and efficacy of the MISSOâ„¢ ROBOTIC SYSTEM.

Meril Life Sciences Pvt Ltd9 sites in 1 country71 target enrollmentStarted: April 30, 2024Last updated:
Conditions

Trial Snapshot

Phase
Unknown
Status
Completed
Sponsor
Enrollment
71
Locations
9
Primary Endpoint
1. Component Alignment - TKA

Study Overview

Brief Summary

MissoBOT: A Prospective, Single-arm, Multi-Center, Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of the MISSO ROBOTIC SYSTEM.

Study Objectives: To Evaluate the Safety and Efficacy of the MISSO ROBOTIC SYSTEM has application throughout the MISSO and is intended for use as a stereotaxic device for knee arthroplasty.

Study Design: A Prospective, Single-arm, Multi-Center, Post-Marketing Surveillance Study.

Background: The surgeon uses a bone saw to remove the arthritically damaged areas at the bottom of the femur and the top of the tibia. Each bone is reshaped to fit its new prosthesis exactly. The procedure is performed manually by the orthopedic surgeons. The MISSO is intended for use as a stereotaxic device for knee arthroplasty. It is to assist a surgeon in planning pre-operation using medical diagnostic images obtained from the patient and to provide orientation and reference information during intra-operative procedures. The surgical tools, under the supervision of the surgeon, perform the pre-operative surgical plan.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18.00 Year(s) to 99.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •1.The subject is willing and able to provide written Informed Consent by signing and dating the IRB or EC approved Informed Consent form.
  • •2.In the case of a subject and LAR being illiterate a literate impartial witness is required during consenting.
  • •3.If the subject is not able to write on behalf of the subject the subjects LAR (Legally acceptable representative) can fill out the informed consent.
  • •4.The subject is willing and able to comply with postoperative scheduled clinical evaluations.
  • •5.Subjects who are able to give voluntary, written informed consent to participate in this clinical investigation and from whom consent has been obtained.
  • •6.The inclusion criteria for the use of MISSO as a stereotaxic device for knee arthroplasty include surgeons seeking assistance in preoperative planning using patients medical diagnostic images and requiring orientation and reference information during intraoperative procedures.
  • •7.Only the participating surgeons who oversee the utilization of surgical tools will execute the preoperative surgical plan while using MISSO as a stereotaxic device for knee arthroplasty.

Exclusion Criteria

  • •1.Without informed consent, the subject is not eligible for the study
  • •If the robotic system of any other brand is used, the subject shouldn’t be included in the study
  • •Individuals with any active infections are excluded.
  • •Individuals exhibiting skeletal immaturity are not considered.
  • •Individuals who can be in situations wherein strong infrared sources or infrared reflectors are present in the vicinity of the trackers are excluded.
  • •Pregnant ladies shall be excluded from the study.
  • •Subjects with a short life expectancy of fewer than 1 year
  • •Subject with a known sensitivity to device materials
  • •Subjects with neuromuscular or neurosensory deficiency that may limit the ability of the patient to evaluate the safety and efficacy of the device
  • •Subjects with a history of deep vein thrombosis or other thrombotic disorders
  • •Subjects with conditions such as severe Parkinsonism and locomotor ataxia that would affect their locomotor stability and interfere with the assessment of the Range of Motion of the target knee
  • •Subjects with severe osteoporosis (T score greater than -3) shall be excluded.

Outcomes

Primary Outcomes

1. Component Alignment - TKA

Time Frame: 1. Time Frame: Post-operative | (Day-0) | 2. TimeFrame:3months | 3. Time Frame: 3 weeks,3months ,6months, 1 year | 4. Time Frame :Pre-Cut and Intraoperative measurements | 5. Time Frame: Intra-operative | 6. TimeFrame:Intra-operative | 7. TimeFrame:PreoperativePlan,3weeks,3months,6months, | 1 year | 8. Time Frame: Postoperative, 3 weeks, 3months, 6months, 1 year

2. Component Alignment-TKA

Time Frame: 1. Time Frame: Post-operative | (Day-0) | 2. TimeFrame:3months | 3. Time Frame: 3 weeks,3months ,6months, 1 year | 4. Time Frame :Pre-Cut and Intraoperative measurements | 5. Time Frame: Intra-operative | 6. TimeFrame:Intra-operative | 7. TimeFrame:PreoperativePlan,3weeks,3months,6months, | 1 year | 8. Time Frame: Postoperative, 3 weeks, 3months, 6months, 1 year

3. Component Alignment - TKA

Time Frame: 1. Time Frame: Post-operative | (Day-0) | 2. TimeFrame:3months | 3. Time Frame: 3 weeks,3months ,6months, 1 year | 4. Time Frame :Pre-Cut and Intraoperative measurements | 5. Time Frame: Intra-operative | 6. TimeFrame:Intra-operative | 7. TimeFrame:PreoperativePlan,3weeks,3months,6months, | 1 year | 8. Time Frame: Postoperative, 3 weeks, 3months, 6months, 1 year

4. Bonecutaccuracy

Time Frame: 1. Time Frame: Post-operative | (Day-0) | 2. TimeFrame:3months | 3. Time Frame: 3 weeks,3months ,6months, 1 year | 4. Time Frame :Pre-Cut and Intraoperative measurements | 5. Time Frame: Intra-operative | 6. TimeFrame:Intra-operative | 7. TimeFrame:PreoperativePlan,3weeks,3months,6months, | 1 year | 8. Time Frame: Postoperative, 3 weeks, 3months, 6months, 1 year

5. Intra-Operative Complications

Time Frame: 1. Time Frame: Post-operative | (Day-0) | 2. TimeFrame:3months | 3. Time Frame: 3 weeks,3months ,6months, 1 year | 4. Time Frame :Pre-Cut and Intraoperative measurements | 5. Time Frame: Intra-operative | 6. TimeFrame:Intra-operative | 7. TimeFrame:PreoperativePlan,3weeks,3months,6months, | 1 year | 8. Time Frame: Postoperative, 3 weeks, 3months, 6months, 1 year

6. Post-resection Soft Tissue Release(STR)and reosteotomy

Time Frame: 1. Time Frame: Post-operative | (Day-0) | 2. TimeFrame:3months | 3. Time Frame: 3 weeks,3months ,6months, 1 year | 4. Time Frame :Pre-Cut and Intraoperative measurements | 5. Time Frame: Intra-operative | 6. TimeFrame:Intra-operative | 7. TimeFrame:PreoperativePlan,3weeks,3months,6months, | 1 year | 8. Time Frame: Postoperative, 3 weeks, 3months, 6months, 1 year

7. Accuracy of total knee arthroplasty component placement

Time Frame: 1. Time Frame: Post-operative | (Day-0) | 2. TimeFrame:3months | 3. Time Frame: 3 weeks,3months ,6months, 1 year | 4. Time Frame :Pre-Cut and Intraoperative measurements | 5. Time Frame: Intra-operative | 6. TimeFrame:Intra-operative | 7. TimeFrame:PreoperativePlan,3weeks,3months,6months, | 1 year | 8. Time Frame: Postoperative, 3 weeks, 3months, 6months, 1 year

8. Adverse Events

Time Frame: 1. Time Frame: Post-operative | (Day-0) | 2. TimeFrame:3months | 3. Time Frame: 3 weeks,3months ,6months, 1 year | 4. Time Frame :Pre-Cut and Intraoperative measurements | 5. Time Frame: Intra-operative | 6. TimeFrame:Intra-operative | 7. TimeFrame:PreoperativePlan,3weeks,3months,6months, | 1 year | 8. Time Frame: Postoperative, 3 weeks, 3months, 6months, 1 year

Secondary Outcomes

  • 1.Radiographic assessment of Limb Alignment(2.Radiographic assessment of prosthesisposition)

Investigators

Sponsor
Meril Life Sciences Pvt Ltd
Sponsor Class
Other [Medical Device Company ]
Responsible Party
Principal Investigator
Principal Investigator

Dr Kirankumar Shetty

Meril Life Sciences Pvt. Ltd

Study Sites (9)

Loading locations...

Similar Trials